The novel GFA analysis resulted in both unique and common genes in the shared active components, including, for instance, well-known cancer oncogenes, such as MYCN and CDKN2A, which were common to all the three data sets, whereas TP53 and KRAS were unique to the MUT data set only (Fig. 3A). Here, CDKN2A is linked to cancer.